Lv4
776 积分 2023-11-04 加入
Pharmacokinetics and Safety of Momelotinib in Subjects With Hepatic or Renal Impairment
1天前
已完结
Pharmacokinetics and Safety of Momelotinib in Subjects With Hepatic or Renal Impairment
1天前
已完结
Mechanism-based inactivation of CYP2D6 by imperatorin and drug-drug interaction in vitro and in vivo
1天前
已完结
Liquid chromatography–tandem mass spectrometric assay for the JAK2 inhibitor CYT387 in plasma
1天前
已完结
Development and Validation of A UPLC–MS/MS Method for Simultaneous Determination of Fotagliptin and its Two Major Metabolites in Human Plasma and Urine
1个月前
已完结
Development and Validation of A UPLC–MS/MS Method for Simultaneous Determination of Fotagliptin and its Two Major Metabolites in Human Plasma and Urine
1个月前
已关闭
Befotertinib: First Approval
1个月前
已完结
Simultaneous quantitation of befotertinib (D-0316) and its metabolite D-0865 in human plasma by LC-MS/MS method
1个月前
已完结
Construction of Humanized CYP1A2 Rats Using CRISPR/CRISPR-Associated Protein 9 to Promote Drug Metabolism and Pharmacokinetic Research
3个月前
已完结
Plumbagin inhibits CYP2J/EETs metabolic pathway and leads to heart injury in cardiac organoids and rats
3个月前
已完结
皖公网安备34019202002308
